GENEXPLAIN GMBH

Am Exer 19 B – Wolfenbuttel – 38302

VAT: DE271983408

http://www.genexplain.com

Complicit EU Projects

Within the Horizon 2020 (2014-2020) framework, GENEXPLAIN GMBH has received € 429,786.0 for its participation in a total of 2 project(s) with a total cost of € 12,890,674.

Start (YYYYMMDD)	Project ID	Project Name	Themes	End (YYYYMMDD)	Role	EC Contribution	Total Cost	IL Participation	Total Participation	CORDIS Link
2018-01-01	754923	COLOSSUS	gender equality · colorectal cancer · mutation · personalized medicine · employment	2023-06-30	participant	€ 281,865.03	€ 5,996,359	1	14	CORDIS ↪
2019-02-01	821522	PD-MitoQUANT	biochemistry · parkinson	2022-07-31	participant	€ 147,921.28	€ 6,894,315	1	15	CORDIS ↪

Showing 1 to 2 of 2 entries

Within the Horizon Europe (2021-2027) framework, GENEXPLAIN GMBH has received € 1,008,750.0 for its participation in a total of 1 project(s) with a total cost of € 9,650,975.

Start (YYYYMMDD)	Project ID	Project Name	Themes	End (YYYYMMDD)	Role	EC Contribution	Total Cost	IL Participation	Total Participation	CORDIS Link
2023-12-01	101136835	HIT-GLIO	surgery · mutation	2027-11-30	participant	€ 1,008,750.0	€ 9,650,975	1	11	CORDIS ↪

Showing 1 to 1 of 1 entries

Within the FP7 (2007-2013) framework, GENEXPLAIN GMBH has received € 1,344,480.0 for its participation in a total of 3 project(s) with a total cost of € 40,346,434.

Start (YYYYMMDD)	Project ID	Project Name	Themes	End (YYYYMMDD)	Role	EC Contribution	Total Cost	IL Participation	Total Participation	CORDIS Link
2012-12-01	305564	SYSMEDIBD	databases · inflammatory bowel disease · microscopy · mathematical model	2017-11-30	participant	€ 499,960.0	€ 15,784,306	1	13	CORDIS ↪
2012-10-01	305280	MIMOMICS	software · proteomics · epidemiology · computational science	2017-09-30	participant	€ 347,800.0	€ 7,883,081	1	15	CORDIS ↪
2011-01-01	258236	SYSCOL	DNA · colorectal cancer · mutation · personalized medicine	2015-12-31	participant	€ 496,720.05	€ 16,679,047	1	11	CORDIS ↪

Showing 1 to 3 of 3 entries